Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Joint Capsule | 1 | 2018 | 7 | 0.660 |
Why?
|
| Gels | 1 | 2018 | 105 | 0.630 |
Why?
|
| Drug Delivery Systems | 2 | 2021 | 669 | 0.510 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 610 | 0.440 |
Why?
|
| Drug Compounding | 2 | 2021 | 70 | 0.210 |
Why?
|
| Drug Carriers | 1 | 2021 | 327 | 0.170 |
Why?
|
| Osteoarthritis, Hip | 1 | 2018 | 17 | 0.160 |
Why?
|
| Injections, Intra-Articular | 1 | 2018 | 32 | 0.160 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 368 | 0.160 |
Why?
|
| Cartilage, Articular | 1 | 2018 | 75 | 0.160 |
Why?
|
| Delayed-Action Preparations | 1 | 2018 | 208 | 0.160 |
Why?
|
| Osteoarthritis, Knee | 1 | 2018 | 162 | 0.140 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 713 | 0.140 |
Why?
|
| Peptides | 1 | 2021 | 1479 | 0.130 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 1048 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2021 | 1058 | 0.120 |
Why?
|
| Injections, Intralesional | 2 | 2021 | 164 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 4367 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2027 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2021 | 3341 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 3578 | 0.070 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 4654 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4557 | 0.060 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2021 | 41 | 0.050 |
Why?
|
| Rats, Inbred BUF | 1 | 2021 | 26 | 0.050 |
Why?
|
| Hydrogels | 1 | 2021 | 123 | 0.050 |
Why?
|
| Quinolones | 1 | 2021 | 160 | 0.050 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 2864 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 29902 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 14289 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7222 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2021 | 1090 | 0.040 |
Why?
|
| Mice | 3 | 2021 | 34495 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2021 | 1026 | 0.030 |
Why?
|
| Male | 3 | 2021 | 123000 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 1439 | 0.030 |
Why?
|
| Female | 3 | 2021 | 141928 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4143 | 0.030 |
Why?
|
| Neoplasms | 1 | 2019 | 15193 | 0.030 |
Why?
|
| Aged | 1 | 2018 | 70117 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 6086 | 0.030 |
Why?
|
| Adult | 1 | 2018 | 77950 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 59536 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 86204 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2021 | 2819 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 6942 | 0.020 |
Why?
|
| Humans | 3 | 2021 | 261506 | 0.020 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 3976 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 14551 | 0.020 |
Why?
|